Key Highlights

  • XRF Scientific Ltd (ASX:XRF) was quoted at AUD 2.12 on 30 October 2026, unchanged for the session; the discussion covers FY26 results and Business operations.
  • FY26 Revenue rose 8% YoY to AUD 64.4 million.
  • XRF Scientific (ASX:XRF) reported a gross Margin of 49.3%, compared with 48.4% in FY25.

XRF Scientific Ltd (ASX:XRF) develops laboratory sample preparation equipment, analytical instruments and related products used by mineral and industrial testing facilities. Its FY26 presentation described instruments, consumables and international distribution. On 30 October 2026, XRF Scientific Ltd (ASX:XRF) was quoted at AUD 2.12, unchanged on the day. The operating discussion below brings together its reported financial performance, business developments and the stated position at the reporting date.

Financial Performance and Comparisons

FY26 revenue rose 8% YoY to AUD 64.4 million. Adjusted profit before tax increased 10% to AUD 16.1 million, while net profit after tax advanced 1% to AUD 10.5 million.

XRF Scientific (ASX:XRF) reported a gross margin of 49.3%, compared with 48.4% in FY25. The reported net-profit change was smaller than adjusted pre-tax growth, with acquisition, international-office and taxation items included in the year.

Operations and Business Activity

Operating cash flow was positive AUD 11.4 million in FY26. The company declared a fully Franked Dividend of 4.5 cents per share, alongside continued Investment in its product range and international presence.

The June quarter generated AUD 17.2 million of revenue and AUD 4.7 million of adjusted profit before tax. Management linked this period with consumables, Orbis crusher sales and international activity.

Capital, Cash and Reporting Measures

On 23 April 2026, XRF Scientific (ASX:XRF) acquired an elemental-analysis instrumentation business for USD 4 million upfront. The transaction added a new analytical product line to its existing laboratory product range.

New international offices were opened in India and the United States. These offices incurred setup and start-up expenses during FY26, which the company separately identified alongside Acquisition costs.

XRF Scientific also outlined uses for its elemental analysis instruments in Manufacturing quality control, including alloys, glass, ceramics and cement. Product development covered laboratory crushing, fusion and automated analysis. The international expansion and equipment acquisitions were undertaken during the financial year rather than being a full-year historical operating contribution.

Current Projects and Reported Outlook

Its Orbis crusher range is designed to prepare large samples for laboratory testing, including automated sample splitting. Other equipment includes fusion machines, platinum laboratory products and instruments used in elemental analysis.

The expanded instrument range covers applications in metals, industrial materials and mineral laboratories. The company described quality-control use cases covering several metals and specialist industrial manufacturing settings.

Key Insights

XRF Scientific Ltd (ASX:XRF) reported a combination of FY26 financial outcomes and activity across its business lines. The latest presentation distinguishes revenue and Earnings measures, operating changes and items relating to later periods. The reported figures should be read with their stated dates and definitions; targets and prospective activity are not the same as completed work or realised earnings.